Heart failure essentials
- Heart failure means the heart is not filling or pumping well enough for the body’s needs; it does not mean the heart has stopped.
- Breathlessness, fatigue, swelling, cough, or reduced activity can occur, but symptoms alone cannot confirm the diagnosis or its type.
- Evaluation combines clinical history, examination, laboratory tests, an ECG, imaging, and the possibility of another cause.
- Treatment and monitoring depend on the person’s stage, heart function, other conditions, preferences, and access to care.
- Severe breathing difficulty, new chest pain or pressure, fainting, or unresponsiveness requires emergency services now.
Emergency symptoms come first
Call emergency services now for severe difficulty breathing, new chest pain or pressure, fainting, or unresponsiveness. Do not wait for a home blood-pressure, pulse, oxygen, or weight reading to change, and do not have the affected person drive. Possible heart-attack, stroke, or dangerous-rhythm symptoms remain emergencies even when someone already has a heart-failure diagnosis.
A rapid change in breathlessness, swelling, cough, fatigue, sleep, or ability to do usual activities also deserves attention. If a person has a written heart-failure action plan, follow its instructions. Otherwise, seek prompt guidance from the treating team. This page cannot supply a universal weight change, fluid amount, blood-pressure number, or pulse that is safe for everyone.
What heart failure means
Heart failure is a clinical syndrome in which the heart cannot fill with blood or pump it forward well enough to meet the body’s needs. The word “failure” can sound as if the heart has stopped. It has not. The term describes a problem with heart function that can affect blood flow, pressures within the heart, and fluid balance.
Heart failure is not one single disease with one cause. Coronary disease, long-standing high blood pressure, heart-muscle disease, valve problems, rhythm disorders, congenital conditions, infections, medicines, and other illnesses can contribute. Sometimes several factors are present. Identifying the likely cause matters because it can change both treatment and what clinicians monitor.
The condition can be chronic, newly recognized, or suddenly worse. Some people have prominent symptoms while others notice only a gradual loss of stamina. A person’s experience cannot reveal the stage or heart-failure phenotype, and feeling better does not by itself show that the underlying condition is gone.
Stages, causes, and ejection-fraction types are different
Clinicians use stages to describe risk and the progression from being at risk through established or advanced disease. They may also describe heart failure by ejection fraction, an imaging measurement of how much blood the left ventricle ejects with each contraction. Reduced, mildly reduced, improved, and preserved ejection-fraction categories help organize clinical decisions, but they are not interchangeable labels.
A preserved ejection fraction does not mean all heart function is normal. Likewise, an ejection fraction that improves does not prove that heart failure is cured or that treatment can be stopped. The number must be interpreted with symptoms, examination, heart structure, laboratory information, other imaging findings, and the broader clinical picture.
It is unsafe to use one scan report or online definition to assign a type to yourself. Measurement methods and timing matter, and kidney disease, blood pressure, rhythm, valve disease, lung disease, anemia, and other conditions can alter the presentation. The treating clinician can explain which terms apply and why.
Symptoms and changes from baseline
Possible symptoms include shortness of breath with activity or at rest, difficulty breathing when lying flat, waking short of breath, fatigue, reduced exercise tolerance, swelling in the legs or abdomen, cough, and a sense that ordinary tasks take more effort. Appetite, concentration, or sleep may also change. None of these symptoms is specific to heart failure.
Lung disease, kidney disease, venous problems, anemia, infection, deconditioning, medicines, and other heart conditions may cause similar changes. Swelling alone does not diagnose heart failure, and the absence of swelling does not exclude it. A wearable alert, one oxygen reading, or a single day’s weight also cannot settle the question.
For someone with diagnosed heart failure, a change from their usual pattern may be more informative than a generic symptom list. Recording what changed, when it began, what activity brings it on, and whether prescribed treatment was available can help the care team. That record supports a clinical conversation; it is not a home severity score.
How clinicians evaluate possible heart failure
Evaluation usually begins with the history and a physical examination. Clinicians may ask about symptom timing, previous heart disease, blood pressure, rhythm problems, family history, medicines, alcohol or other exposures, sleep, pregnancy history, and conditions affecting the lungs, kidneys, thyroid, or blood. Examination may look for congestion, circulation changes, heart or lung findings, and other explanations.
Testing can include an ECG, blood tests, chest imaging, and an echocardiogram or other heart imaging. Different tests answer different questions. A biomarker can support the evaluation but is affected by age, kidney function, body composition, rhythm, and clinical setting. One laboratory value cannot diagnose, exclude, stage, or predict the course of heart failure on its own.
Clinicians combine the findings to determine whether the syndrome is present, identify a likely cause, describe stage and phenotype, and look for conditions that change care. Sometimes evaluation continues over more than one visit. New severe symptoms should never be delayed while waiting for a routine outpatient test.
Why phenotype and other conditions shape care
Heart failure with reduced ejection fraction and heart failure with preserved ejection fraction have overlapping symptoms but different evidence and treatment considerations. Even within one phenotype, decisions vary with blood pressure, kidney function, potassium and other electrolytes, heart rhythm, valve disease, diabetes, coronary disease, lung disease, frailty, and medication tolerance.
Care also changes with setting. A stable clinic visit, a recent hospitalization, and an acute episode of congestion are not the same situation. Guidance intended for one phenotype or setting should not be copied into another. Children, people with congenital heart disease, and those who are pregnant or postpartum need condition- and life-stage-specific expertise.
Access matters too. Medicine cost, transportation, food and housing security, disability, language, caregiving, and the ability to monitor at home can determine whether a plan is workable. Naming these constraints helps the team build safer care; they are not evidence of poor motivation.
What treatment may include
Treatment aims can include easing congestion and symptoms, treating contributing causes, supporting heart function, reducing avoidable complications, and helping a person maintain daily life. Depending on the diagnosis, care may involve several medicines, management of related conditions, selected devices or procedures, cardiac rehabilitation or other supervised activity support, and coordinated follow-up.
There is no safe universal medicine sequence, dose, or titration schedule for a public guide. Choices depend on phenotype, stage, blood pressure, kidney function, electrolytes, rhythm, comorbidities, side effects, pregnancy potential, and access. Never stop, skip, double, borrow, or substitute a diuretic, beta blocker, anticoagulant, or other cardiovascular medicine based on general information.
Devices and procedures are appropriate only for selected people after specialist evaluation. They are not automatic consequences of an ejection-fraction category. Ask what problem a proposed intervention is intended to address, what alternatives exist, what follow-up it requires, and how the decision fits personal goals.
Monitoring and a personal action plan
Monitoring may include symptoms, examination, laboratory tests, blood pressure, rhythm, imaging, and selected home observations. The right combination and frequency differ by person and may change after a hospital stay, medicine adjustment, or new illness. More measurements are not automatically safer if no one has explained how to respond.
A written action plan should state which changes to watch, whom to contact, and what requires emergency help. Some plans include weight, swelling, breathing, or blood-pressure instructions, but the thresholds must come from the treating team. Copying another person’s fluid restriction, sodium goal, diuretic adjustment, or daily-weight rule can cause harm.
Bring a current medicine list, home records the team requested, and notes about side effects or missed access to visits. Report nonprescription pain relievers, cold medicines, herbal products, and supplements because they can interact with heart-failure care. Do not wait for the next routine appointment if symptoms are worsening.
Living with diagnosed heart failure
Daily care is easier when it fits the person’s abilities, culture, resources, work, and support network. Rehabilitation and appropriately tailored movement can improve function for many people, but an article cannot provide exercise clearance. New chest symptoms, fainting, severe breathlessness, or an acute decline should be assessed before increasing activity.
Nutrition and fluid guidance must account for symptoms, kidney function, medicines, blood pressure, and other conditions. A universal restriction is not appropriate. Vaccination, sleep, smoking cessation support, mental health, dental care, and management of diabetes or lung disease may be part of coordinated care, depending on the individual.
Caregivers can help track changes, organize medicines, attend visits, and understand emergency plans when the person agrees. Fatigue, anxiety, low mood, cognitive changes, and caregiver strain deserve discussion. Good care includes function and quality of life, not only test results.
Questions for a care visit
Ask what evidence supports the diagnosis, what likely caused or contributed to it, and which stage and phenotype apply. Clarify what the ejection-fraction result does and does not mean. Ask whether another condition could be contributing to breathlessness, fatigue, swelling, or reduced function.
Review each medicine’s purpose, important side effects, monitoring, affordability, and what to do if a dose or supply is disrupted. Ask which home observations are useful, the personal thresholds for calling, and which symptoms require emergency services. Have the team put those instructions in writing.
Discuss rehabilitation, activity, work, travel, nutrition, fluid questions, sleep, vaccines, and emotional support in the context of your health. Ask how kidney function, blood pressure, diabetes, rhythm, or coronary disease changes the plan. Shared decisions should reflect both medical evidence and what matters to the person.
Official sources
- NHLBI: What Is Heart Failure?
- NHLBI: Heart Failure Symptoms
- NHLBI: Heart Failure Treatment
- AHA/ACC/HFSA: 2022 Heart Failure Guideline
- ACC/AHA/HFSA: Second Universal Definition of Heart Failure
- ACC: 2024 HFrEF Expert Consensus Decision Pathway
- ACC: 2026 HFpEF Expert Consensus Decision Pathway
- American Heart Association: When to Call 911